Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-053744
Filing Date
2025-04-14
Accepted
2025-04-14 16:44:20
Documents
109
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K emma-20241231.htm   iXBRL 10-K 4395965
2 EX-10.9 emma-ex10_9.htm EX-10.9 215007
3 EX-10.48 emma-ex10_48.htm EX-10.48 559921
4 EX-21.1 emma-ex21_1.htm EX-21.1 7334
5 EX-23.1 emma-ex23_1.htm EX-23.1 6455
6 EX-23.2 emma-ex23_2.htm EX-23.2 4475
7 EX-31.1 emma-ex31_1.htm EX-31.1 11529
8 EX-31.2 emma-ex31_2.htm EX-31.2 11253
9 EX-32.1 emma-ex32_1.htm EX-32.1 8776
10 GRAPHIC img50099120_0.jpg GRAPHIC 104660
11 GRAPHIC img50099120_1.jpg GRAPHIC 100163
12 GRAPHIC img116725616_0.jpg GRAPHIC 124070
13 GRAPHIC img261618995_0.jpg GRAPHIC 5821
14 GRAPHIC img261618995_1.jpg GRAPHIC 34846
15 GRAPHIC img261618995_2.jpg GRAPHIC 34846
16 GRAPHIC img261618995_3.jpg GRAPHIC 2226
17 GRAPHIC img261618995_4.jpg GRAPHIC 10382
18 GRAPHIC img261618995_5.jpg GRAPHIC 948
19 GRAPHIC img261618995_6.jpg GRAPHIC 7311
20 GRAPHIC img261618995_7.jpg GRAPHIC 1172
21 GRAPHIC img261618995_8.jpg GRAPHIC 1246
22 GRAPHIC img261618995_9.jpg GRAPHIC 2365
23 GRAPHIC img261618995_10.jpg GRAPHIC 1246
24 GRAPHIC img261618995_11.jpg GRAPHIC 2365
25 GRAPHIC img261618995_12.jpg GRAPHIC 3429
26 GRAPHIC img261618995_13.jpg GRAPHIC 12177
  Complete submission text file 0000950170-25-053744.txt   20108420

Data Files

Seq Description Document Type Size
27 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT emma-20241231.xsd EX-101.SCH 1996971
112 EXTRACTED XBRL INSTANCE DOCUMENT emma-20241231_htm.xml XML 4308513
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35527 | Film No.: 25836494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)